Inventor · disambiguated record
B. Michael Longenecker
Also filed as: LONGENECKER B M · LONGENECKER B MICHAEL
15 granted patents·6 pending applications·209 citations·filing 1988–2015
93Inventor score
Top patents by PatentIndex Score
21 records- 0190US6600012B1Lipid-modified muc-1 derivativesBIOMIRA INC·Filed 2000·Granted Jul 29, 2003·43 cites·16 claims
- 0286US5110911AHuman tumor-associated thomsen-friedenreich antigenBIOMIRA INC·Filed 1989·Granted May 5, 1992·84 cites·6 claims
- 0382USRE38046EEnhancement of the cellular immune responseBIOMIRA INC·Filed 2000·Granted Mar 25, 2003·10 cites·63 claims
- 0477US8552145B2Vaccine for modulating between T1 and T2 immune responsesBUDZYNSKI WLADYSLAW A·Filed 2012·Granted Oct 8, 2013·2 cites·13 claims
- 0574US8871250B2Method of treating patients with a mucinous glycoprotein (MUC-1) vaccineLONGENECKER B MICHAEL·Filed 2006·Granted Oct 28, 2014·2 cites·28 claims
- 0672US8198400B2Vaccine for modulating between T1 and T2 immune responsesBUDZYNSKI WLADYSLAW A·Filed 2002·Granted Jun 12, 2012·5 cites·34 claims
- 0762US6602660B1Methods of detecting T-cell activationFiled 2000·Granted Aug 5, 2003·4 cites·6 claims
- 0861US9119784B2Method of treating patients with a mucinous glycoprotein (MUC-1) vaccineONCOTHYREON INC·Filed 2014·Granted Sep 1, 2015·0 cites·24 claims
- 0959US5242799ALectin-antibody immunoassays for TF epitope-bearing antigensBIOMIRA INC·Filed 1992·Granted Sep 7, 1993·27 cites·24 claims
- 1058US6582697B2Enhancement of the cellular immune responseBIOMIRA INC·Filed 2001·Granted Jun 24, 2003·0 cites·14 claims
- 1158US5798090AEnhancement of the cellular immune responseBIOMIRA INC·Filed 1995·Granted Aug 25, 1998·14 cites·10 claims
- 1251US4971795AEnhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotypeBIOMIRA INC·Filed 1988·Granted Nov 20, 1990·11 cites·9 claims
- 1350US9173929B2Mucinous glycoprotein (MUC-1) vaccineLONGENECKER B MICHAEL·Filed 2005·Granted Nov 3, 2015·0 cites·27 claims
- 1447US2006069238A1Synthetic glyco-lipo-peptides as vaccinesBIOMIRA INC·Filed 2003·Application pending·0 cites
- 1547US2002044943A1MUC-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditionsFiled 2001·Application pending·0 cites
- 1646US2015359868A1Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) VaccineONCOTHYREON INC·Filed 2015·Application pending·0 cites
- 1743US2004247608A1Imunogenic conjugate of carbohydrate haptens and aggregated protein carrierFiled 2002·Application pending·0 cites
- 1841US6114129AMethods of detecting T-cell activation and treating disorders associated with T-cell dysfunctionBIOMIRA INC·Filed 1999·Granted Sep 5, 2000·7 cites·5 claims
- 1941US2016082093A1Mucinous glycoprotein (muc-1) vaccineONCOTHYREON INC·Filed 2015·Application pending·0 cites
- 2039US2002142983A1MUC-1 antagonists and methods of treating immune disordersBIOMIRA INC·Filed 2001·Application pending·0 cites
- 2130US6326009B1Enhancement of the cellular immune responseBIOMIRA INC·Filed 1998·Granted Dec 4, 2001·0 cites·61 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →